DaVita
DVA
#1963
Rank
NZ$17.08 B
Marketcap
NZ$255.55
Share price
1.19%
Change (1 day)
-0.26%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): NZ$17.32

According to DaVita's latest financial reports the company's current EPS (TTM) is NZ$17.24. In 2024 the company made an earnings per share (EPS) of NZ$18.79 an increase over its 2023 EPS that were of NZ$12.97.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$17.32-7.83%
2024NZ$18.7944.94%
2023NZ$12.9727.26%
2022NZ$10.19-35.56%
2021NZ$15.8144.1%
2020NZ$10.9719.7%
2019NZ$9.17540.48%
2018NZ$1.43-76.07%
2017NZ$5.98-19.31%
2016NZ$7.41242.52%
2015NZ$2.16-62.87%
2014NZ$5.8313.43%
2013NZ$5.148.45%
2012NZ$4.74

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
NZ$36.38 110.97%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$17.46 1.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
NZ$25.05 45.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
NZ$3.24-81.24%๐Ÿ‡บ๐Ÿ‡ธ USA